Navigation Links
2013 BioProcess Theater Presentations Now Available on the BioProcess International Digital Media Website
Date:6/13/2013

New York, NY (PRWEB) June 13, 2013

BioProcess International (BPI) announces the online publication of the complete set of BPI Theater podcasts presented during the 2013 BIO International Convention, 22–25 April in Chicago, IL.

Now in its seventh year, the BioProcess Theater is a 50-seat amphitheater located at the heart of the BioProcess Zone in the BIO International Conference exhibit hall. The BPI Theater provides attendees with daily opportunities to listen, learn, and interact with leading experts as they present, discuss, and debate the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

BPI Theater podcast presentations include the following:

Biosimilars

  •     Pfenex and Agila Biotech Biosimilars Joint Venture: The Convergence of Expression and Manufacturing Technology Harnessing the Emerging Market Opportunity
  •     Developing and Manufacturing Biosimilars and Biobetters
  •     Biosimilars: Challenges and Solutions
  •     The Highs and Lows of Manufacturing a Biosimilar
  •     Biosimilar Development Concerns: Collaboration, Capacity, and CMOs

Single-Use Processing

  •     Purification and Concentration of Nanoparticles using Single-Use TFF
  •     Process Evolution from the Iron Age to the New Age: A Transition from a Stainless Steel and Glass to a Full Disposable Upstream Process
  •     Building and Operating a Single-Use Facility: Reducing Time, Cost, and Risk
  •     Flexible Facilities: Strategies for Supplying Complex Biologics in a Changing Global Market
  •     Accelerating BioProcess Development Using Microbioreactors
  •     Processing Biologics Using a Disposable Production Train?

Cell Therapy

  •     Defining Critical Parameters for Scale-Up and Process Control in Cell Therapy
  •     Leveraging a CMO to Optimize the Financial and Operational Efficiency of an Emerging Cell Therapy Business
  •     Case Study: Scale-Up Strategy for Liver Stem Cell Therapy
  •     Serum-Free Culture of Mesenchymal Stem Cells
  •     CGMP Compliance Trends for Cellular Therapeutics and the Challenges in Late-Stage Commercial Ready Manufacturing

Antibody/Non-Antibody Manufacturing

  •     Optimized Solutions for Better Biologic Treatments
  •     Case Study: The Effect of Upstream Process Changes on HCP Composition and Detection
  •     New Endotoxin Detection and Removal Methods in Downstream Processing of Biologics
  •     Bioconjugates – From Targets to Therapeutics

Vaccine Manufacturing

  •     Development of Protein Capsular Matrix Vaccine (PCMV) Platform Technology
  •     Simpler and More Efficient Vaccine Manufacturing
  •     In Silico and In Vitro tools for Accelerated Vaccine Design
  •     Five Traits of Successful Vaccine Development and Production

Featured presenters represent a broad range of companies throughout the global industrial biotherapeutic community including Advanced Bioscience Laboratories, Inc.; Agila Biotech; ATMI LifeSciences; Avid Bioservices, Inc.; BioGenes; BiogenIdec; BioProcess Technology Consultants; Boehringer Ingelheim; Boston Oncology; Catalent Pharma Solutions; Centrose; Cobra Biologics; Corning Life Sciences; Cytovance Biologics; EMD Millipore; Gallus BioPharmaceuticals, Inc.; GE Healthcare; Hospira; Hyglos, GmbH; ImClone Systems; ImmunoGen, Inc.; Latham Biopharm Group; Laureate Biopharma; Lonza; Lonza Custom Manufacturing; M&W Group; m2p Labs; Malaysian Bio-XCell Sdn Bhd; Matrivax Research and Development Corp.; PCT Cell Therapy Services; Pfenex; PolyPeptide Group; PolyTherics; Promethera Biosciences; Sanofi Pasteur, Spectrum Laboratories; Inc.; WuXi AppTec; and Xcellerex.

BPI Theater podcasts are available free online as part of the BioProcess International Digital Media website (http://www.bpidm.com/bpi-theater).

About BioProcess International

BioProcess International™ (http://www.bioprocessintl.com) is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process.

BioProcess International™ is part of the IBC Life Sciences Division of Informa, plc, a leading international provider of specialist information and services for the academic, professional and business communities. Informa offers a world-class portfolio of publications, events and data services for researchers, students, lecturers and professionals in the academic and scientific communities worldwide.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10832281.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. BioProcess International May 2013 Issue Published on the App Store Featuring App-only Exclusive Content
2. The Columbia Center for Theatrical Arts (CCTA) Announces Its Theater Program for Special Needs Youth
3. CABARET! Evening of Music, Songs and Laughter to Benefit Children's Theater
4. Maryland Children's Theater Holds Auditions for Summer Youth Productions of SHREK! and Les Misérables
5. Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy May 27th 7:00 PM
6. AAO-HNSF 2012 new poster presentations
7. Implicit race bias increases the differences in the neural representations of black and white faces
8. Automated autism screening tool available on Autism Speaks website
9. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
10. Polar RCX5 Tour de France Available At The Heart Rate Watch Company
11. IntelliQuote Works to Educate Consumers about the Importance of Life Insurance Protection and to Make Coverage More Readily Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial Healthcare ... Graduate Medical Education (ACGME) that it has received accreditation for its residency program ... three residency programs that Memorial is currently pursuing, including Pediatrics and Internal Medicine. ...
(Date:4/29/2016)... Calif. (PRWEB) , ... April 29, 2016 , ... Our ... An effective way to confront and deal with these stressors is to adopt a ... to be good for you. Risa Groux, a certified Holistic Nutritionist and the creator ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American workforce is ... even security. Most importantly, employees are the single most important asset in creating ... so unhappy? , Just under half of American workers are emotionally checked out ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced efforts ... more information about their loan terms and accounts, and more protections for borrowers. ... federal and private loans, has reached $1.3 trillion, with 43 million Americans holding ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating ... new location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. ... Smart TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
Breaking Medicine Technology: